Drugs & Targets Cleave Biosciences’s CB-5083 receives FDA orphan drug designation July 17, 2015Vol.41 No.28
Drugs & Targets FDA grants orphan drug designation to ImMucin in multiple myeloma July 17, 2015Vol.41 No.28
In Brief Georgetown Lombardi and John Theurer to Form Cancer Research Consortium July 17, 2015Vol.41 No.28
Iressa Returns to U.S. Market— Now with Companion Diagnostic July 17, 2015Vol.41 No.28By Paul Goldberg
In Brief Synexus opens three clinical trial research centers in Eastern Europe July 17, 2015Vol.41 No.28
